ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1858

Hypervigiliance in Fibromyalgia

Robert S. Katz1, Ben J. Small2, Susan Shott1 and Sharon M. Ferbert3, 1Rush University Medical Center, Chicago, IL, 2MacNeal Hospital, Berwyn, IL, 3Advocates for Funding Fibromyalgia Treatment, Education and Research(AFFTER), Libertyville, IL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: fibromyalgia

  • Tweet
  • Email
  • Print
Session Information

Title: Fibromyalgia and Soft Tissue Disorders

Session Type: Abstract Submissions (ACR)

Background/Purpose: Patients with fibromyalgia syndrome (FMS) experience severe chronic pain and usually are tender to touch. They are hyperactive to weather changes and stress. Do FMS patients perceive physical pain the way they are hypersensitive to their environment? Are FMS patients more likely to be hypervigilant? Hypervigilance is a symptom associated with post-traumatic stress disorder, experience an exaggerated sense of threat in their surroundings that is disproportionate to reality. They are easily set off and startled by mild stimuli and feel anxious in public.

Methods: 128 office patients with fibromyalgia (FMS) or rheumatoid arthritis (RA) (111 women, 17 men; mean age 51 ± 13) completed a questionnaire about hypervigilance symptoms. 100 patients had FMS and 28 had RA. The chi-square test of association and Fisher’s exact test were used to compare the responses of FMS and RA patients, with a two-sided 0.05 significance level. As a part of an Internet survey administered by the volunteer community fibromyalgia organization AFFTER, 763 female self-identified FMS patients and 115 female controls without FMS responded to questions asking if they experience the symptoms common to hypervigilance. Only women’s responses were analyzed to eliminate confounding by gender. Percentages were compared using the chi-square test of association with a 0.05 significance level.

Results: FMS patients were more likely than RA patients to report hypervigilance symptoms: waking up more than once during the nights, FMS 75.0%, RA 46.4% (p = 0.004); feeling uncomfortable in crowded places, FMS 57.6%, RA 25.0% (p = 0.002); feeling uncomfortable if people are standing behind them, FMS 33.0%, RA 10.7% (p = 0.021); and easily startled, FMS 59.4%, RA 29.6% (p = 0.006)


In the Internet questionnaire The mean respondent age was 49.8 ± 11.4 years. 73.9% of FMS and 45.4% of controls were easily startled (p < 0.001). 57.4% of FMS and 30.2% of controls reported that they did not feel at ease around strangers (p < 0.001). 77.2% of FMS reported feeling uncomfortable in crowded places, versus to 42.7% of controls (p < 0.001). 44.9% of FMS and 16.5% of controls reported feeling uncomfortable if people are standing behind them (p < 0.001). For, easily “let their hair down”, only 39.1% of FMS said yes, versus 66.0% of controls (p < 0.001). 32.7% of FMS and 15.5% of controls do not find it easy to trust people  (p = 0.001). Easy for other people to pull the wool over their eyes, FMS responded yes (45.9%) more often than controls (32.0%) (p = 0.009). 32.5% of FMS and 11.3% of controls found themselves disliking people for no reason (p < 0.001). 75.0% of FMS and 21.6% of controls had trouble falling asleep(p < 0.001). 86.8% of FMS said they wake up more than once a night to 48.5% of controls (p < 0.001).


Conclusion: Results suggest that FMS patients are more aware of social and environmental stressors and more likely to be hypervigilant. They have trouble sleeping and are more easily startled. They are less likely to trust their surroundings. Hypervigilance might confer a survival advantage in threatening circumstances, but the hyper-reactivity associated with the condition could also be associated with the central sensitization of pain and dysesthesias, insomnia and other symptoms associated with FMS.


Disclosure:

R. S. Katz,
None;

B. J. Small,
None;

S. Shott,
None;

S. M. Ferbert,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hypervigiliance-in-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology